Bibliographic information
Guideline—
Year of Publication—
Issuing Institution—
Recommendation
Maintained
Originally developed
In patients with confirmed rifampicin-susceptible and isoniazid-resistant tuberculosis, treatment with rifampicin, ethambutol, pyrazinamide and levofloxacin is recommended for a duration of 6 months
Recommended in favor
Conditional
Certainty of evidence
Very low
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
WHO consolidated guidelines on tuberculosis: Module 4: Treatment - Drug-resistant tuberculosis treatment
Year2020
InstitutionWorld Health Organization